Predictors of Response to Carbamazepine Extended-Release Capsules Treatment in Bipolar Disorder

ISSN： 1040-1237

Source： Annals of Clinical Psychiatry (after Jan 1, 2004), Vol.18, Iss.1, 2006-03, pp. : 23-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carbamazepine Extended-Release Capsules in the Treatment of Bipolar Disorder

By Ginsberg Lawrence

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 1, 2006-03 ,pp. : 1-1

Informa Healthcare

Access to resources Recommend Favorite

Outcomes and Length of Treatment With Carbamazepine Extended-Release Capsules in Bipolar Disorder

By Ginsberg Lawrence

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 1, 2006-03 ,pp. : 15-18

Informa Healthcare

Access to resources Recommend Favorite

Safety of Carbamazepine Extended-Release Capsules in Bipolar Disorder Polypharmacy

By Ginsberg Lawrence

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 1, 2006-03 ,pp. : 19-22

Informa Healthcare

Access to resources Recommend Favorite

A Retrospective Analysis of Changing From Alternative Agents to Carbamazepine Extended-Release Capsules in Bipolar Disorder

By Ginsberg Lawrence

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 1, 2006-03 ,pp. : 31-34

Informa Healthcare

Access to resources Recommend Favorite

Safety and Efficacy of Carbamazepine Extended-Release Capsules in Patients With Bipolar Disorder: QD vs BID

By Ginsberg Lawrence

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 1, 2006-03 ,pp. : 27-30

Informa Healthcare

Access to resources Recommend Favorite